. Author manuscript; available in PMC: 2021 Mar 3.

Published in final edited form as: JACC Heart Fail. 2019 Dec;7(12):1032–1041. doi: 10.1016/j.jchf.2019.08.018

Table 2.

Blood Pressure Management Medication Use During the Trial by Randomized Group

Medications	Overall (n=9361)	Treatment Arm		p-value
Medications	Overall (n=9361)	Standard (n=4683)	Intensive (n=4678)	p-value
Any diuretic	7335 (78.4%)	3227 (68.9%)	4108 (87.8%)	<.0001
Any ACE-I or ARB	7830 (83.6%)	3628 (77.5%)	4202 (89.8%)	<.0001
Any beta blockers	4413 (47.1%)	2006 (42.8%)	2407 (51.5%)	<.0001
Any Calcium channel blockers	6146 (65.7%)	2670 (57.0%)	3476 (74.3%)	<.0001

ACE-I =Angiotensin converting enzymes Inhibitors; ARB=Angiotensin II antagonists.

This table shows the medication and percentage that ever used from randomization until August 20, 2015